The COVID-19 pandemic threatens to reverse recent progress in reducing the global burden of tuberculosis. The global number of deaths for tuberculosis could increase by around 200.000–400.000 in 2020 alone, as result of essential tuberculosis services disruptions due to the reallocation of human, financial and other resources from tuberculosis to the COVID-19 response, as reported by WHO: https://bit.ly/35KyzD
A European-African partnership aimed at improving the ethics and regulatory capacity of clinical research in Central African countries has successfully proposed its project (AfriHetique) to the European Commission (EDCTP). The partnership
“This project will improve malaria prevention strategies for both children, pregnant women and families as a whole as the study is being conducted in families which will raise awareness of
Ebola vaccine candidates are currently being evaluated in phase I–III clinical trials conducted in Africa, the EU and the US. Although preclinical development of candidate vaccines utilise different platforms, including